Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 9 | 7 | 10 | — | 1 | 24 |
Castration-resistant prostatic neoplasms | D064129 | — | — | 4 | 3 | 5 | — | — | 10 |
Neoplasms | D009369 | — | C80 | 3 | 1 | 2 | — | 2 | 7 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | — | 5 | — | — | 5 |
Bone neoplasms | D001859 | EFO_0003820 | D16 | — | — | 4 | — | — | 4 |
Bone marrow diseases | D001855 | — | — | — | — | 4 | — | — | 4 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | 2 | — | 1 | 3 |
Anemia | D000740 | EFO_0004272 | D64.9 | — | 2 | 1 | — | 1 | 3 |
Second primary neoplasms | D016609 | — | — | — | — | 2 | — | — | 2 |
Multiple myeloma | D009101 | — | C90.0 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sarcoma | D012509 | — | — | 1 | — | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | 1 | — | — | — | — | 1 |
Intestinal neoplasms | D007414 | — | C26.0 | 1 | — | — | — | — | 1 |
Recurrence | D012008 | — | — | 1 | — | — | — | — | 1 |
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal cell carcinoma | D002292 | EFO_0000376 | — | — | — | — | — | 1 | 1 |
Colorectal neoplasms | D015179 | — | — | — | — | — | — | 1 | 1 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | — | — | — | 1 | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | — | 1 | 1 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | — | — | — | — | 1 | 1 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | — | 1 | 1 |
Esophageal neoplasms | D004938 | — | C15 | — | — | — | — | 1 | 1 |
Lung neoplasms | D008175 | — | C34.90 | — | — | — | — | 1 | 1 |
Urinary bladder neoplasms | D001749 | — | C67 | — | — | — | — | 1 | 1 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | — | — | — | 1 | 1 |
Drug common name | Aglatimagene besadenovec |
INN | aglatimagene besadenovec |
Description | Aglatimagene besadenovec is a gene pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Gene |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL3544993 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 5Z72SSS34W (ChemIDplus, GSRS) |